Emily Kathleen Zern, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ventricular Dysfunction, Right | 2 | 2023 | 581 | 0.710 |
Why?
|
Heart Failure | 9 | 2023 | 10900 | 0.650 |
Why?
|
Neprilysin | 1 | 2020 | 439 | 0.590 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 451 | 0.570 |
Why?
|
Protease Inhibitors | 1 | 2020 | 791 | 0.540 |
Why?
|
Waiting Lists | 1 | 2020 | 692 | 0.530 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1537 | 0.530 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1073 | 0.520 |
Why?
|
Exercise Test | 6 | 2022 | 2074 | 0.490 |
Why?
|
Tetrazoles | 1 | 2020 | 835 | 0.480 |
Why?
|
Pulmonary Artery | 2 | 2023 | 1912 | 0.480 |
Why?
|
Exercise Tolerance | 5 | 2021 | 770 | 0.460 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2023 | 1536 | 0.430 |
Why?
|
Pulmonary Wedge Pressure | 3 | 2022 | 264 | 0.420 |
Why?
|
Heart Arrest | 2 | 2024 | 1470 | 0.400 |
Why?
|
Hypothermia, Induced | 1 | 2016 | 752 | 0.400 |
Why?
|
Heart Transplantation | 2 | 2020 | 3110 | 0.300 |
Why?
|
Hemodynamics | 4 | 2021 | 4199 | 0.300 |
Why?
|
Patient Care Team | 1 | 2017 | 2531 | 0.270 |
Why?
|
Stroke Volume | 5 | 2022 | 5007 | 0.270 |
Why?
|
Pulmonary Embolism | 1 | 2017 | 2376 | 0.240 |
Why?
|
Palliative Care | 1 | 2016 | 3493 | 0.200 |
Why?
|
Ventricular Function, Right | 2 | 2023 | 591 | 0.200 |
Why?
|
Drug Users | 1 | 2022 | 134 | 0.180 |
Why?
|
Shock, Cardiogenic | 1 | 2024 | 688 | 0.160 |
Why?
|
Endocarditis, Bacterial | 1 | 2022 | 455 | 0.160 |
Why?
|
Endocarditis | 1 | 2022 | 350 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2022 | 525 | 0.150 |
Why?
|
Intensive Care Units | 2 | 2023 | 3679 | 0.150 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1616 | 0.140 |
Why?
|
Biphenyl Compounds | 1 | 2020 | 913 | 0.130 |
Why?
|
Ilium | 1 | 2016 | 154 | 0.130 |
Why?
|
Dyspnea | 2 | 2020 | 1303 | 0.130 |
Why?
|
Mitral Valve | 1 | 2023 | 1491 | 0.130 |
Why?
|
Drug Combinations | 1 | 2020 | 1959 | 0.120 |
Why?
|
Heart-Assist Devices | 2 | 2022 | 1194 | 0.120 |
Why?
|
HIV Antigens | 1 | 2013 | 347 | 0.110 |
Why?
|
Tissue and Organ Harvesting | 1 | 2016 | 369 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1889 | 0.100 |
Why?
|
Ventricular Function, Left | 2 | 2021 | 3670 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2886 | 0.100 |
Why?
|
Viremia | 1 | 2013 | 736 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2788 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3508 | 0.090 |
Why?
|
Middle Aged | 11 | 2024 | 213383 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2925 | 0.090 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 980 | 0.080 |
Why?
|
Humans | 20 | 2024 | 744343 | 0.080 |
Why?
|
Heart | 1 | 2022 | 4467 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3952 | 0.080 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2161 | 0.080 |
Why?
|
Aged | 7 | 2023 | 163280 | 0.080 |
Why?
|
Male | 12 | 2024 | 350118 | 0.070 |
Why?
|
Tissue Donors | 1 | 2016 | 2240 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1643 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 2538 | 0.060 |
Why?
|
Female | 11 | 2023 | 380194 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5034 | 0.060 |
Why?
|
Hypertension | 1 | 2023 | 8480 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7913 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.060 |
Why?
|
Internship and Residency | 1 | 2023 | 5788 | 0.060 |
Why?
|
Obesity | 2 | 2023 | 12745 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9856 | 0.050 |
Why?
|
Adult | 6 | 2022 | 214055 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4665 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2020 | 63114 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 21746 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40075 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 23403 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15165 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2023 | 2715 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2023 | 77449 | 0.030 |
Why?
|
HIV-1 | 1 | 2013 | 6939 | 0.030 |
Why?
|
Adiponectin | 1 | 2021 | 1100 | 0.030 |
Why?
|
Risk Factors | 1 | 2022 | 72290 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2023 | 1076 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15076 | 0.030 |
Why?
|
Diskectomy | 1 | 2016 | 206 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.030 |
Why?
|
Leptin | 1 | 2021 | 1599 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 310 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2021 | 3200 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2291 | 0.020 |
Why?
|
Bone Transplantation | 1 | 2016 | 907 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2559 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2021 | 3864 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 16718 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2016 | 1241 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8554 | 0.020 |
Why?
|
Exercise | 1 | 2022 | 5615 | 0.020 |
Why?
|
Viral Load | 1 | 2013 | 3299 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 53288 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5524 | 0.010 |
Why?
|
Kidney | 1 | 2018 | 7186 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10638 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4386 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 12804 | 0.010 |
Why?
|